GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Price-to-Owner-Earnings

Raia Drogasil (BSP:RADL3) Price-to-Owner-Earnings

: (As of Today)
View and export this data going back to 1995. Start your Free Trial

As of today (2024-04-23), Raia Drogasil's share price is R$25.53. Raia Drogasil does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Raia Drogasil's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Raia Drogasil was 608.28. The lowest was 21.10. And the median was 88.24.


BSP:RADL3's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 20.225
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-23), Raia Drogasil's share price is R$25.53. Raia Drogasil's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R$0.62. Therefore, Raia Drogasil's PE Ratio for today is 41.18.

As of today (2024-04-23), Raia Drogasil's share price is R$25.53. Raia Drogasil's EPS without NRI for the trailing twelve months (TTM) ended in was R$0.53. Therefore, Raia Drogasil's PE Ratio without NRI for today is 48.63.

During the past 13 years, Raia Drogasil's highest PE Ratio without NRI was 228.79. The lowest was 27.17. And the median was 47.87.


Raia Drogasil Price-to-Owner-Earnings Historical Data

The historical data trend for Raia Drogasil's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.35 40.74 34.87 183.93 -

Raia Drogasil Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.93 58.05 83.38 109.60 -

Competitive Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil Price-to-Owner-Earnings Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Price-to-Owner-Earnings falls into.



Raia Drogasil Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Raia Drogasil's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=25.53/-0.14
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (BSP:RADL3) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Raia Drogasil Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines